Free Newsletter
Biovail CEO challenged to TV debate; Mylan nabs Effexor approval
> The proxy fight between Biovail founder Eugene Melnyk and the company's management took a weird turn as the man Melnyk wants to head the company challenged its current CEO to a televised debate. Report
> Mylan Pharmaceuticals got the FDA's final nod for its copycat version of Effexor and plans to ship immediately; the company also got a tentative nod for its version of Sanofi Aventis' blood pressure med Avalide. Report
> Allergan received FDA approval for Trivaris, an injectable eye drug to treat retinal diseases. Report
> The Florida Medical Examiners Commission found that the rate of deaths caused by prescription drugs was three times the rate of deaths caused by all illicit drugs combined. Report
> Schering-Plough spent $520,000 in the first quarter to lobby on patent reform legislation, drug safety and other issues, according to a disclosure report. Report
> Medtronic got FDA approval to market its Starfix lead, a wire that delivers electrical pulses to the heart from a device that regulates heartbeat. Report
And Finally... How can doctors ensure patients take their medicine? Simple, give them a reward. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





